blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2417129

EP2417129 - TRIAZINE-ARYL-BIS-INDOLES AS PDE-4 INHIBITORS USEFUL FOR THE TREATMENT OF ASTHMA [Right-click to bookmark this link]
Former [2012/07]TRIAZINE-ARYL-BIS-INDOLES AND PROCESS FOR PREPARATION THEREOF
[2015/42]
StatusNo opposition filed within time limit
Status updated on  27.01.2017
Database last updated on 01.10.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Council of Scientific & Industrial Research
Anusandhan Bhawan, 2 Rafi Marg
New Delhi 110 001 / IN
[2012/07]
Inventor(s)01 / GANGAVARAM, Vasanta, Madhava, Sharma
Indian Institute of Chemical Technology
Uppal Road
500607 Hyderabad / IN
02 / YADAV, Jhillu, Singh
Indian Institute of Chemical Technology
Uppal Road
500607 Hyderabad / IN
03 / PALAKODETY, Radha, Krishna
Indian Institute of Chemical Technology
Uppal Road
500607 Hyderabad / IN
04 / BANDYOPADHYAY, Arun
Indian Institute of Chemical Biology
4 Raja S C Mullick Road
700032 Kolkata / IN
05 / ROY, Siddhartha
Indian Institute of Chemical Biology
4 Raja S C Mullick Road
700032 Kolkata / IN
06 / BANDYOPADHYAY, Santu
Indian Institute of Chemical Biology
4 Raja S C Mullick Road
700032 Kolkata / IN
07 / JOHRI, Rakesh, Kamal
Indian Institute of Integrative Medicine
Canal Road
180001 Jammu / IN
08 / SHARMA, Subhash, Chander
Indian Institute of Integrative Medicine
Canal Road
180001 Jammu / IN
09 / GHOSH, Balaram
Institute of Genomics and Integrative Biology
Near Jubilee Hall
Mall Road
110007 New Delhi / IN
10 / ULAGANATHAN, Mabalirajan
Institute of Genomics and Integrative Biology
Near Jubilee Hall
Mall Road
110007 New Delhi / IN
11 / BALWANI, Sakshi
Institute of Genomics and Integrative Biology
Near Jubilee Hall
Mall Road
110007 New Delhi / IN
12 / PAUL, Bholanath
Indian Institute of Toxicology Research
Mahatma Gandhi Marg
226001 Lucknow / IN
13 / SAXENA, Ashok, Kumar
Indian Institute of Toxicology Research
Mahatma Gandhi Marg
226001 Lucknow / IN
 [2012/07]
Representative(s)Gevers & Orès
Immeuble le Palatin 2
3 Cours du Triangle
CS 80165
92939 Paris La Défense Cedex / FR
[N/P]
Former [2016/12]Gevers & Orès
36 rue de Saint-Pétersbourg
75008 Paris / FR
Former [2012/07]Mena, Sandra, et al
Cabinet Orès 36, rue de St Pétersbourg
F-75008 Paris / FR
Application number, filing date10812801.831.12.2010
[2016/12]
WO2010IB03375
Priority number, dateIN2010DEL017529.01.2010         Original published format: IN DE01752010
[2012/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011092547
Date:04.08.2011
Language:EN
[2011/31]
Type: A1 Application with search report 
No.:EP2417129
Date:15.02.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 04.08.2011 takes the place of the publication of the European patent application.
[2012/07]
Type: B1 Patent specification 
No.:EP2417129
Date:23.03.2016
Language:EN
[2016/12]
Search report(s)International search report - published on:EP04.08.2011
ClassificationIPC:C07D403/14, C07D251/52, C07D251/50, A61K31/53, A61P11/06
[2012/07]
CPC:
C07D403/14 (EP,US); A61K31/53 (EP,US); A61P11/06 (EP);
C07D251/50 (EP,US); C07D251/52 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/07]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:TRIAZIN-ARYL-BIS-INDOLE ALS PDE-4 HEMMER VERWENDBAR FÜR DIE BEHANDLUNG VON ASTHMA[2015/42]
English:TRIAZINE-ARYL-BIS-INDOLES AS PDE-4 INHIBITORS USEFUL FOR THE TREATMENT OF ASTHMA[2015/42]
French:TRIAZINE-ARYL-BIS-INDOLES COMME INHIBITEURS DE PDE-4 UTILES POUR LE TRAITEMENT DE L'ASTHME[2015/42]
Former [2012/07]TRIAZIN-ARYL-BIS-INDOLE UND HERSTELLUNGSVERFAHREN DAFÜR
Former [2012/07]TRIAZINE-ARYL-BIS-INDOLES AND PROCESS FOR PREPARATION THEREOF
Former [2012/07]TRIAZINE-ARYL-BIS-INDOLES ET LEUR PROCÉDÉ DE FABRICATION
Entry into regional phase09.11.2011National basic fee paid 
09.11.2011Designation fee(s) paid 
09.11.2011Examination fee paid 
Examination procedure09.11.2011Examination requested  [2012/07]
15.06.2012Amendment by applicant (claims and/or description)
02.05.2014Despatch of a communication from the examining division (Time limit: M06)
29.10.2014Reply to a communication from the examining division
30.09.2015Communication of intention to grant the patent
18.01.2016Fee for grant paid
18.01.2016Fee for publishing/printing paid
18.01.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.05.2014
Opposition(s)02.01.2017No opposition filed within time limit [2017/09]
Fees paidRenewal fee
24.10.2012Renewal fee patent year 03
30.09.2013Renewal fee patent year 04
30.09.2014Renewal fee patent year 05
30.09.2015Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.12.2010
AL23.03.2016
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
TR23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
CH31.12.2016
IE31.12.2016
LI31.12.2016
LU31.12.2016
MT31.12.2016
[2018/46]
Former [2018/43]HU31.12.2010
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
TR23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
CH31.12.2016
IE31.12.2016
LI31.12.2016
LU31.12.2016
MT31.12.2016
Former [2018/29]HU31.12.2010
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
TR23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
CH31.12.2016
IE31.12.2016
LI31.12.2016
LU31.12.2016
Former [2018/28]HU31.12.2010
AT23.03.2016
BE23.03.2016
CY23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
MK23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
CH31.12.2016
IE31.12.2016
LI31.12.2016
LU31.12.2016
Former [2017/51]AT23.03.2016
BE23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
CH31.12.2016
IE31.12.2016
LI31.12.2016
LU31.12.2016
Former [2017/49]AT23.03.2016
BE23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
CH31.12.2016
IE31.12.2016
LI31.12.2016
LU31.12.2016
Former [2017/47]AT23.03.2016
BE23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
MC23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/37]AT23.03.2016
BE23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SI23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/20]AT23.03.2016
BE23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
BG23.06.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/07]AT23.03.2016
BE23.03.2016
CZ23.03.2016
DK23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2017/03]AT23.03.2016
BE23.03.2016
CZ23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
IT23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2016/51]AT23.03.2016
CZ23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
PT25.07.2016
Former [2016/50]AT23.03.2016
CZ23.03.2016
EE23.03.2016
ES23.03.2016
FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RO23.03.2016
RS23.03.2016
SE23.03.2016
SK23.03.2016
SM23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
Former [2016/49]EE23.03.2016
FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
PL23.03.2016
RS23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
Former [2016/48]FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
RS23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
IS23.07.2016
Former [2016/40]FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
NL23.03.2016
RS23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
Former [2016/39]FI23.03.2016
HR23.03.2016
LT23.03.2016
LV23.03.2016
RS23.03.2016
SE23.03.2016
NO23.06.2016
GR24.06.2016
Former [2016/36]FI23.03.2016
HR23.03.2016
LT23.03.2016
NO23.06.2016
GR24.06.2016
Former [2016/35]FI23.03.2016
HR23.03.2016
NO23.06.2016
GR24.06.2016
Cited inInternational search[X]US3451802  (NEIGHBORS RALPH P, et al) [X] 10 * column 3, line 65 - column 4, line 9; example 1 *;
 [A]DD154572  (GUENTHER EBERHARD, et al) [A] 10 * page 7, last compound of table I;;; claim 1 *;
 [AD]  - F. LEROUX ET AL, "Phosphodiesterase 4 inhibitors as airways smooth muscle relaxant agents: synthesis and biological activities of triazine derivatives", BIOORGANIC & MEDICINAL CHEMISTRY, (1999), vol. 7, no. 3, pages 509 - 516, XP002634142 [AD] 1-17 * the whole document *
 [A]  - NEIL J. PRESS AND KATHARINE H. BANNER, "2 PDE4 inhibitors - A review of the current field", PROGRESS IN MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, (2009), vol. 47, ISSN 0079-6468, pages 37 - 74, XP009142806 [A] 1-17 * the whole document *
 [X]  - R. M. DESAI ET AL, "Simple and efficient synthetic routes to bioactive s-triazinyl dithiocarbamate derivatives", MEDICINAL CHEMISTRY RESEARCH, BIRKHÄUSER-VERLAG, BO, (20080214), vol. 17, no. 8, doi:DOI:10.1007/S00044-008-9093-4, ISSN 1554-8120, pages 495 - 506, XP019658489 [X] 10 * scheme 1, compounds 2;;; table 1; compounds 2a-2j *

DOI:   http://dx.doi.org/10.1007/s00044-008-9093-4
 [A]  - G. V. M. SHARMA ET AL, "A versatile and practical synthesis of bis(indolyl)methanes/bis(indol yl)glycoconjugates catalyzed by trichloro-1,3,5-triazine", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 45, no. 41, doi:DOI:10.1016/J.TETLET.2004.08.084, ISSN 0040-4039, (20041004), pages 7729 - 7732, (20040917), XP022797442 [A] 1-7,13 * scheme 1;;; compounds 3a,14a *

DOI:   http://dx.doi.org/10.1016/j.tetlet.2004.08.084
by applicantUS6288104
 JPH11158073
    - DONNELLY, L. E.; ROGERS, D. F., "Therapy for COPD in the 21", DRUGS, (2003), vol. 63, pages 1973 - 1998
    - YEOUNG, K,-P, DRUG DISCOVERY TODAY, (2009), vol. 14, pages 812 - 813
    - HOUSLAY, M. D.; SCHAFER, P.; ZHANG, K, Y. J., DRUG DISCOVERY TODAY, (2005), vol. 10, pages 1503 - 1519
    - DAL PIAZ, V.; GIOVANNONI, M. P., EUR. J. MED. CHEM., (2000), vol. 35, page 463480
    - GIEMBYCZ, M. A., MONALDI ARCH CHEST DIS., (2002), vol. 57, pages 48 - 64
    - MOLFINO, N. A., RESPIRATION, (2005), vol. 72, pages 105 - 112
    - CONTI, M.; BEAVO, J., ANNU. REV. BIOCHEM., (2007), vol. 76, pages 481 - 511
    - MULLER, T.; ENGELS, P.; FOZARD, J. R., TRENDS PHARMACOL. SCI., (1996), vol. 17, pages 294 - 298
    - TEIXEIRA, M. M.; GRISTWOOD, R. W.; COOPER, N.; HELLEWELL, P. G., PDE-4 INHIBITORS: TRENDS PHARMACOL. SCI., (1997), vol. 18, pages 164 - 170
    - SMITH, M.; CROUCH, N.; GERICKE, N.; HIRST, M., "Psychoactive constituents of the genus Sceletium N.E.Br. and other Mesembryanthemaceae: review", J. ETHNOPHARMACOL, (1996), vol. 50, doi:doi:10.1016/0378-8741(95)01342-3, pages 119 - 30, XP002040528

DOI:   http://dx.doi.org/10.1016/0378-8741(95)01342-3
    - GRISWOLD, D. E.; WEBB, E. F.; BRETON, J.; WHITE, J. R.; MARSHALL, P. J.; TORPHY, T. J., "Effect of selective phosphodiesterase type 1V inhibitor, rolipram, on fluid and cellular phases of inflammatory response", INFLAMMATION, (1993), vol. 17, doi:doi:10.1007/BF00918994, pages 333 - 4, XP001064263

DOI:   http://dx.doi.org/10.1007/BF00918994
    - SCHNEIDER, H. H.; SCHMIECHEN, R.; BREZNISKI, M.; SEIDLER, J., EUR. J. PHARMOCOL., (1986), vol. 127, pages 105 - 115
    - PROFITA, M; CHIAPPARA G; MIRABELLA, F; CHIMENTI, G DI, L; COSTANZO, G; RICCOBONO, L; BELLIA V; BOUSQUET J; VIGNOLA A, EFFECT OF CILOMILAST (ARIFLO) ON TNF-, IL-8 AND GM-CSF RELEASE BY AIRWAY CELLS OF PATIENTS WITH COPD, (2003), vol. 58, pages 573 - 579
    - OCHIAI, H.; OHTANI, T.; ISHIDA, A.; KUSUMI, K.; KATO, M.; KOHNO, H.; KISHIKAWA, K.; OBATA, T.; NAKAI, H.; TODA, M., BIOORG. MED. CHEM. LETT., (2004), vol. 14, pages 207 - 10
    - HATZELMANN, A.; SCHUDT, C., J. PHARMACOL. EXP. THER., (2001), vol. 297, pages 267 - 290
    - SOUNESS, J. E.; RAO, S., CELL SIGNAL, (1997), vol. 9, pages 227 - 236
    - DUPLANTIER, A. J. ET AL., J. MED. CHEM., (1996), vol. 39, pages 120 - 125
    - HIGUCHI, K.; KAWASAKI, T., NAT. PRO. REP., (2007), vol. 24, pages 843 - 868
    - O'CONNOR, S. E.; MARESH, J., NAT. PRO. REP., (2006), vol. 23, pages 532 - 547
    - OLGEN, S.; KAESSLER, K.; NEBIOGLU, D.; JOACHIM, J., CHEM. BIOL. DRUG DES., (2007), vol. 70, pages 547 - 551
    - SMART, B. P.; OSLUND, R. S.; WALSH, L. A.; GELB, M., N. J. MED CHEM., (2006), vol. 49, pages 2858 - 2860
    - HOPKINS, C. R. ET AL., BIOORG. MED. CHEM. LETT., (2005), vol. 15, pages 2734 - 2737
    - KUSS, H.; HOEFGEN, N.; JOHANSSEN, S.; KRONBACH, T.; RUNDFELDT, C. J., PHARMACOL. EXP. THER., (2003), vol. 307, pages 373 - 385
    - LEROUX, F.; VAN KEULEN, B. J.; DALIERS, J.; POMMERY, N.; HENICHART, J. P., BIOORG. MED. CHEM. LETT., (1999), vol. 7, pages 509 - 516
    - RAVIKANTH, V.; IMELDA, 0.; WAGNER-DOBLER, 1.; LAATSCH, H. J., NAT. PRO., (2003), vol. 66, pages 1520 - 1523
    - TAKAGI, K.; HATTORI, T.; KUNISADA, H.; YUKI, Y., JOURNAL OF POLYMER SCIENCE: PART A: POLYMER CHEMISTRY, (2000), vol. 38, pages 4385 - 4395
    - KO ET AL., BIOCHEMICAL PHARMACOLOGY, (2004), vol. 68, pages 2087 - 2094
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.